Q32 Bio
QTTB
QTTB
118 hedge funds and large institutions have $240M invested in Q32 Bio in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
12% less capital invested
Capital invested by funds: $273M → $240M (-$33.1M)
69% less call options, than puts
Call options by funds: $322K | Put options by funds: $1.04M
Holders
118
Holding in Top 10
2
Calls
$322K
Puts
$1.04M
Top Buyers
| 1 | +$5.45M | |
| 2 | +$4.14M | |
| 3 | +$3.58M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.54M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.38M |
Top Sellers
| 1 | -$7.89M | |
| 2 | -$4.31M | |
| 3 | -$3.1M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$932K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$774K |